AstraZeneca PLC (AZN)
65.63
+1.37
(+2.13%)
USD |
NASDAQ |
Nov 22, 16:00
65.64
0.00 (0.00%)
After-Hours: 20:00
AstraZeneca Cash from Financing (Quarterly): -4.131B for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -4.131B |
| June 30, 2024 | -1.222B |
| March 31, 2024 | 2.028B |
| December 31, 2023 | -291.00M |
| September 30, 2023 | -2.726B |
| June 30, 2023 | -1.519B |
| March 31, 2023 | -2.031B |
| December 31, 2022 | -358.00M |
| September 30, 2022 | -1.43B |
| June 30, 2022 | -1.295B |
| March 31, 2022 | -3.74B |
| December 31, 2021 | -1.051B |
| September 30, 2021 | 142.00M |
| June 30, 2021 | 7.289B |
| March 31, 2021 | -2.731B |
| December 31, 2020 | -2.21B |
| September 30, 2020 | 1.243B |
| June 30, 2020 | 1.126B |
| March 31, 2020 | -2.362B |
| December 31, 2019 | 6.00M |
| September 30, 2019 | -2.712B |
| June 30, 2019 | 1.639B |
| March 31, 2019 | -698.00M |
| December 31, 2018 | -1.732B |
| September 30, 2018 | 169.00M |
| Date | Value |
|---|---|
| June 30, 2018 | 182.00M |
| March 31, 2018 | -663.00M |
| December 31, 2017 | -12.00M |
| September 30, 2017 | -3.07B |
| June 30, 2017 | 2.188B |
| March 31, 2017 | -2.042B |
| December 31, 2016 | -304.00M |
| September 30, 2016 | -1.014B |
| June 30, 2016 | 1.355B |
| March 31, 2016 | -1.361B |
| December 31, 2015 | 4.284B |
| September 30, 2015 | -1.018B |
| June 30, 2015 | 181.00M |
| March 31, 2015 | -2.569B |
| December 31, 2014 | 1.151B |
| September 30, 2014 | -1.286B |
| June 30, 2014 | -358.00M |
| March 31, 2014 | -2.212B |
| December 31, 2013 | 201.00M |
| September 30, 2013 | -1.112B |
| June 30, 2013 | 96.00M |
| March 31, 2013 | -2.232B |
| December 31, 2012 | -525.00M |
| September 30, 2012 | -242.00M |
| June 30, 2012 | -718.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-4.131B
Minimum
Sep 2024
7.289B
Maximum
Jun 2021
-763.15M
Average
-1.258B
Median
Cash from Financing (Quarterly) Benchmarks
| GSK PLC | -1.718B |
| Amgen Inc | -3.651B |
| Johnson & Johnson | -9.882B |
| Sanofi SA | -- |
| Moderna Inc | 11.00M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.383B |
| Cash from Investing (Quarterly) | -1.514B |
| Free Cash Flow | 6.757B |
| Free Cash Flow Per Share (Quarterly) | 0.6482 |
| Free Cash Flow to Equity (Quarterly) | 4.177B |
| Free Cash Flow to Firm (Quarterly) | 2.240B |
| Free Cash Flow Yield | 3.29% |